China and India battle fake drugs


China and India are the two biggest sources of illegal copies of branded drugs.

The world's pharmaceutical giants spend millions developing new treatments, so the battle to prevent counterfeit copies of their products is vital to protect that investment.

However, Scott Davies from Pfizer told the BBC's Asia Business Report that governments should also see it as an issue of safety for consumers.

Copyright © 2017 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.